Heat Biologics' Series A Round

Heat Biologics raised a round of funding on May 21, 2010. Investors include Brightline Ventures.

Heat Biologics is a clinical-stage company focused on developing its off-the-shelf ImPACT therapeutic vaccines to combat a wide range of cancers and infectious diseases. ImPACT Therapy exploits the na…

Articles about Heat Biologics' Series A Round: